{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"159"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"212"}],"units":"Participants"}],"description":"Determine the incidence of platelet engraftment (platelet recovery \\>50,000/uL) at 6 months after UCBT.","groups":[{"description":"Patients undergoing unrelated umbilical cord blood transplantation (UCBT) for hematologic malignancies treated with myeloablative preparative regimen comprising fludarabine phosphate, mycophenolate mofetil, filgrastim, cyclophosphamide, cyclosporine and fractionated total-body irradiation.","id":"OG000","title":"Unrelated UCBT for Blood Cancers"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"6 months","title":"Number of Participants With Platelet Engraftment","type":"SECONDARY","unitOfMeasure":"Participants"}